(Q44083110)

29 November 2017

title

Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases (English)

1 reference

Solbritt Rantapää Dahlqvist

29 November 2017

author

6

1 reference

29 November 2017

Marta Christensson

1

1 reference

29 November 2017

Erna Pettersson

2

1 reference

29 November 2017

Kjell Eneslätt

3

1 reference

29 November 2017

Birger Christensson

4

1 reference

29 November 2017

Johan Bratt

5

1 reference

29 November 2017

Karl-Gösta Sundqvist

7

1 reference

29 November 2017

publication date

1 July 2002

1 reference

Journal of Clinical Immunology

29 November 2017

published in

1 reference

29 November 2017

volume

22

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

220-227

1 reference

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

29 November 2017

cites work

1 reference

12 December 2020

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

1 reference

12 December 2020

Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis

1 reference

12 December 2020

Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus

1 reference

12 December 2020

Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis

1 reference

12 December 2020

Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases

1 reference

12 December 2020

The role of Fas and related death receptors in autoimmune and other disease states

1 reference

12 December 2020

Fas ligand, death gene.

1 reference

12 December 2020

Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

1 reference

12 December 2020

Increase in CD95 (Fas/APO-1)-positive CD4+ and CD8+ T cells in peripheral blood derived from patients with autoimmune hepatitis or chronic hepatitis C with autoimmune phenomena

1 reference

12 December 2020

Systemic autoimmune disease as a consequence of defective lymphocyte death

1 reference

12 December 2020

Fas-Fas ligand system in the peripheral blood of patients with renal diseases

1 reference

12 December 2020

In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG)

1 reference

12 December 2020

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

12 December 2020

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

12 December 2020

T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission

1 reference

12 December 2020

Pathological findings in human autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus

1 reference

12 December 2020

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

12 December 2020

T cell activation in patients with ANCA-associated vasculitis: inefficient immune suppression by therapy

1 reference

12 December 2020

Role of Fas/FasL interaction in physiology and pathology: the good and the bad.

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Fas ligand expression and function in systemic lupus erythematosus

1 reference

12 December 2020

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

1 reference

12 December 2020

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

1 reference

12 December 2020

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

12 December 2020

Pathogenesis of ANCA-associated systemic vasculitis

1 reference

12 December 2020

Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1016040925295

1 reference

Dimensions Publication ID

29 November 2017

1026693702

0 references

1 reference